Literature DB >> 17171992

[Italian Network on Congestive Heart Failure: ten-year experience].

Gianna Fabbri1, Marco Gorini, Aldo P Maggioni, Giuseppe Cacciatore, Andrea Di Lenarda.   

Abstract

IN-CHF is a multicenter registry, designed in 1995 to compile a large clinical database on the epidemiological, clinical characteristics, management and outcomes of heart failure outpatients. Main objectives of IN-CHF registry were to provide cardiological centers with a software to collect data of outpatients during office visit, for educational purpose; and to enter local data into a national registry (IN-CHF registry), for scientific purpose. Entry into the database required a diagnosis of heart failure according to the guidelines of the European Society of Cardiology. The central coordinator of the project was the ANMCO Research Center. The Italian cardiological centers participating in the project are 142, they are well representing the entire country and from March 1995 to July 2005 collected data from 23 855 outpatients. The mean age of the patients was 65+/-13 years and 71.3% were men. Main etiologies were ischemic in 39.4%, hypertensive in 15.8 %, and due to dilated cardiomyopathy in 29%. More than half of the patients (55.3%) had a history of admission for heart failure within the last year; 25.8% of the patients were in NYHA class III-IV, 9.5% showed a heart rate > 100 bpm and 16.5% third heart sound. Left ventricular ejection fraction was severely depressed (< 30%) in 27.6% of the patients, while it was > 40% in 30.9%. Renal dysfunction was present in 3.6% of the patients (serum creatinine level > 2.5 mg/dl), pulmonary disease in 18.7%, diabetes in 16.8% and anemia (hemoglobin < 12 g/dl) in 18.7%. A history of arterial hypertension was common (30.3%); 20.0% and 18.5% of the patients showed atrial fibrillation and left bundle branch block, respectively. Data from our registry provide important insights into clinical and epidemiological characteristics of heart failure outpatients followed in Italian cardiological centers. Starting from this article, every 3 months, the most relevant epidemiological data collected by the IN-CHF investigators will be published.

Entities:  

Mesh:

Year:  2006        PMID: 17171992

Source DB:  PubMed          Journal:  G Ital Cardiol (Rome)        ISSN: 1827-6806


  4 in total

1.  Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.

Authors:  Kenneth C Bilchick; Yongfei Wang; Alan Cheng; Jeptha P Curtis; Kumar Dharmarajan; George J Stukenborg; Ramin Shadman; Inder Anand; Lars H Lund; Ulf Dahlström; Ulrik Sartipy; Aldo Maggioni; Karl Swedberg; Chris O'Conner; Wayne C Levy
Journal:  J Am Coll Cardiol       Date:  2017-05-30       Impact factor: 24.094

2.  Heart Failure in a Dedicated Outpatient Clinic: Results after 58 Month Follow-Up. Can it be Enough?

Authors:  M Mirra; G Vitulano; N Virtuoso; N Tufano; F D'Auria; S De Angelis; R Giudice; A Lambiase; A Gigantino; F Piscione
Journal:  Transl Med UniSa       Date:  2014-12-19

3.  Risk-adjustment models for heart failure patients' 30-day mortality and readmission rates: the incremental value of clinical data abstracted from medical charts beyond hospital discharge record.

Authors:  Jacopo Lenzi; Vera Maria Avaldi; Tina Hernandez-Boussard; Carlo Descovich; Ilaria Castaldini; Stefano Urbinati; Giuseppe Di Pasquale; Paola Rucci; Maria Pia Fantini
Journal:  BMC Health Serv Res       Date:  2016-09-06       Impact factor: 2.655

4.  Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes.

Authors:  Kenneth C Bilchick; Yongfei Wang; Jeptha P Curtis; Ramin Shadman; Todd F Dardas; Inder Anand; Lars H Lund; Ulf Dahlström; Ulrik Sartipy; Wayne C Levy
Journal:  J Am Heart Assoc       Date:  2022-06-29       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.